Plain-English translation of NCT06362629 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing an artificial intelligence app designed to help people with atopic dermatitis (a chronic skin condition that causes itching, redness, and irritation) manage their condition better. The app uses deep learning—a type of AI trained on thousands of skin images—to automatically detect and evaluate the severity of skin symptoms. Researchers want to see if using this app helps people control their atopic dermatitis better than standard care alone.
Atopic dermatitis can be difficult to manage because patients and doctors need to carefully track how the skin is improving or worsening over time. This trial exists to see whether an AI tool that automatically evaluates skin condition could make management easier, more consistent, and more effective.
You likely qualify if…
You likely don't qualify if…
If you join the app group, you will use the AI app to help track your skin during treatment and have follow-up visits at 2 weeks, 4 weeks, 8 weeks, 12 weeks, 6 months, and 12 months. At each visit, doctors will take images of your skin and measure how well your symptoms have improved using standard skin assessments. The control group will receive standard face-to-face dermatology care without the app, with follow-up timing decided by their doctor. The trial lasts about one year.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China